ConductScience.org, home

Trial · NCT01698775

Participant flow12

How many started, completed or left each group, period by period.

PeriodMilestoneGroupParticipantsUnits counted
Phase ASTARTEDOmarigliptin (Phase A) → Omarigliptin (Phase B)107
Phase ASTARTEDPlacebo to Omarigliptin (Phase A) → Glipizide (Phase B)106
Phase ACOMPLETEDOmarigliptin (Phase A) → Omarigliptin (Phase B)98
Phase ACOMPLETEDPlacebo to Omarigliptin (Phase A) → Glipizide (Phase B)97
Phase ANOT COMPLETEDOmarigliptin (Phase A) → Omarigliptin (Phase B)9
Phase ANOT COMPLETEDPlacebo to Omarigliptin (Phase A) → Glipizide (Phase B)9
Phase BSTARTEDOmarigliptin (Phase A) → Omarigliptin (Phase B)98
Phase BSTARTEDPlacebo to Omarigliptin (Phase A) → Glipizide (Phase B)97
Phase BCOMPLETEDOmarigliptin (Phase A) → Omarigliptin (Phase B)84
Phase BCOMPLETEDPlacebo to Omarigliptin (Phase A) → Glipizide (Phase B)86
Phase BNOT COMPLETEDOmarigliptin (Phase A) → Omarigliptin (Phase B)14
Phase BNOT COMPLETEDPlacebo to Omarigliptin (Phase A) → Glipizide (Phase B)11

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT01698775/flow